AnGes MG Inc. | Ownership
Companies that own AnGes MG Inc.
Monega Kapitalanlagegesellschaft mbH
50,000
0.06%
0
0.04%
07/31/2018
SSgA Funds Management, Inc.
49,800
0.06%
0
0%
09/06/2018
Asset Management One Co., Ltd.
30,000
0.03%
30,000
0%
08/29/2017
GO ETF Solutions LLP
11,000
0.01%
11,000
0%
02/28/2018
Bayview Asset Management Co., Ltd.
5,999
0.01%
5,999
0.26%
11/27/2017
Guardians of New Zealand Superannuation
0
0%
-4,400
0%
06/30/2017
Norges Bank Investment Management
0
0%
-379,778
0%
12/31/2017
| Address |
Saito Bio-Incubator 1F
Osaka Osaka 567
Japan
|
|
Employees
|
- |
| Website |
http://www.anges.co.jp |
| Updated |
07/08/2019 |
| AnGes, Inc. engages in the research and development of gene-based medical products. It offers genetic medicines such as hepatocyte growth factor (HGF) genetic medicines, NF-KB decoy oligo and hemagglutinating virus of Japan envelope (HVJ-E) non-viral vector, and others. It is also involved in the research and development of medical equipment, which improves blood circulation by regenerating blood vessels and NfkB which controls various inflammations. |
